Request for Information (RFI): Inviting Comments on the National Institutes of Health's (NIH) Strategic Plan for Data Science 2023-2028, 2629-2630 [2024-00696]

Download as PDF Federal Register / Vol. 89, No. 10 / Tuesday, January 16, 2024 / Notices Agenda: To review and evaluate grant applications. Place: National Center for Complementary and Integrative, Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892. Contact Person: Michael Eric Authement, Ph.D., Scientific Review Officer, Office of Scientific Review, Division of Extramural Activities, 6707 Democracy Boulevard, Bethesda, MD 20817, michael.authement@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training in Complementary and Alternative Medicine, National Institutes of Health, HHS) Dated: January 9, 2024. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–00628 Filed 1–12–24; 8:45 am] in Complementary and Alternative Medicine, National Institutes of Health, HHS) Dated: January 9, 2024. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–00633 Filed 1–12–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information (RFI): Inviting Comments on the National Institutes of Health’s (NIH) Strategic Plan for Data Science 2023–2028 AGENCY: BILLING CODE 4140–01–P National Institutes of Health, HHS. ACTION: DEPARTMENT OF HEALTH AND HUMAN SERVICES National Center For Complementary & Integrative Health; Notice of Closed Meeting ddrumheller on DSK120RN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Complementary and Integrative Health Special Emphasis Panel; HEAL Initiative: Toward Developing Quantitative Imaging and Other Relevant Biomarkers of Myofascial Tissues for Clinical Pain Management (R61/ R33, Clinical Trial Required). Date: February 16, 2024. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Center for Complementary and Integrative Health, Democracy II, 6707 Democracy Blvd., Bethesda, MD 20892. Contact Person: Shiyong Huang, Ph.D., Scientific Review Officer, Office of Scientific Review, Division of Extramural Activities, NCCIH/NIH, 6707 Democracy Boulevard, Suite 401, Bethesda, MD 20817, shiyong.huang@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.213, Research and Training 18:57 Jan 12, 2024 Jkt 262001 The purpose of this Request for Information (RFI) is to solicit public comments on the updated NIH Strategic Plan for Data Science, 2023–2028, including members of the scientific community, academic institutions, the private sector, health professionals, professional societies, advocacy groups, and patient communities, as well as other interested members of the public. DATES: The NIH Request for Information is open for public comment. To assure consideration, your response must be received by March 15, 2024, 11:59 p.m. (ET). ADDRESSES: All comments must be submitted electronically on the submission website at https://data science.nih.gov/rfi-strategic-plan or to the mailbox at strategic-plan-rfi@ od.nih.gov. Responses must be received by 11:59:59 p.m. (ET) on March 15, 2024. Responses to this RFI are voluntary and may be submitted anonymously. You may voluntarily include your name and contact information with your response. If you choose to provide NIH with this information, NIH will not share your name and contact information outside of NIH unless required by law. Other than your name and contact information, please do not include any personally identifiable information or any information that you do not wish to make public. Proprietary, classified, confidential, or sensitive information should not be included in your response. The government will use the information submitted in response to this RFI at its discretion. Other than your name and contact information, the government reserves the right to use any submitted information on public SUMMARY: National Institutes of Health VerDate Sep<11>2014 Request for information. PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 2629 websites, in reports, in summaries of the state of the science, in any possible resultant solicitation(s), grant(s), or cooperative agreement(s), or in the development of future funding opportunity announcements. This RFI is for informational and planning purposes only and is not a solicitation for applications or an obligation on the part of the government to provide support for any ideas identified in response to it. Please note that the government will not pay for the preparation of any information submitted or for use of that information. We look forward to your input and hope that you will share this RFI opportunity with your colleagues. FOR FURTHER INFORMATION CONTACT: Questions about this request for information should be directed to Dr. Susan Gregurick, 301–538–9781, strategic-plan-rfi@od.nih.gov, National Institutes of Health, Office of Data Science Strategy, 9000 Rockville Pike, Bethesda, Maryland 20892. SUPPLEMENTARY INFORMATION: NIH is requesting public comment on topics under consideration for the updated NIH Strategic Plan for Data Science, 2023–2028 from its partners and collaborators, including members of the scientific community, academic institutions, the private sector, health professionals, professional societies, advocacy groups, and patient communities, as well as other interested members of the public. This RFI is in accordance with 42 U.S.C. 281 as amended. Background The updated Strategic Plan for Data Science (https://datascience.nih.gov/ sites/default/files/NIH-STRATEGICPLAN-FOR-DATA-SCIENCE-2023-2028final-draft.pdf) sets a bold vision for the future, one in which data generated in the course of care of individuals and data generated from biomedical and basic research become powerful inputs that enhance our understanding of fundamental biology and enables the development of new clinical treatments and diagnostic technologies. This updated plan builds on accomplishments from the initial NIH Strategic Plan for Data Science (https:// datascience.nih.gov/nih-strategic-plandata-science) and will prepare NIH to face the acceleration of sophisticated new technologies and address the rapid rise in the quantity and diversity of data. The updated Strategic Plan supports the NIH Policy for Data Management and Sharing (https:// sharing.nih.gov/data-management-andsharing-policy) and embraces data- E:\FR\FM\16JAN1.SGM 16JAN1 2630 Federal Register / Vol. 89, No. 10 / Tuesday, January 16, 2024 / Notices driven discovery as a powerful tool to elucidate biological processes and better characterize the health and health consequences of all people. This plan also fosters ethical use of new methodologies arising from artificial intelligence and machine learning. The updated Strategic Plan will accomplish five overarching goals: • Goal 1: Improve Capabilities to Sustain the NIH Policy for Data Management and Sharing • Goal 2: Develop Programs to Enhance Human Derived Data for Research • Goal 3: Provide New Opportunities in Software, Computational Methods, and Artificial Intelligence • Goal 4: Support for a Federated Biomedical Research Data Infrastructure • Goal 5: Strengthen a Broad Community in Data Science The complete draft plan is available at: https://datascience.nih.gov/sites/ default/files/NIH-STRATEGIC-PLANFOR-DATA-SCIENCE-2023-2028-finaldraft.pdf. ddrumheller on DSK120RN23PROD with NOTICES1 Information Requested NIH is requesting public comment throughout the scientific research community and members of the general public for the updated NIH Strategic Plan for Data Science. NIH encourages organizations (e.g., patient advocacy groups, professional organizations) to submit a single response reflective of the views of the organization or membership as a whole. Response to this RFI is voluntary. Respondents are free to address any or all topics listed below, as well as other relevant topics, for NIH’s consideration. If you choose to provide NIH with this information, NIH will not share your name and contact information outside of NIH unless required by law. The NIH seeks comments on any of the following topics: • The appropriateness of the goals of the plan, the strategies and implementation tactics proposed to achieve them; including potential benefits, drawbacks or challenges. • Opportunities for NIH to partner to achieve these goals. • Emerging research needs and opportunities that should be added to the plan. • Any other topic the respondent feels is relevant for NIH to consider in developing this strategic plan. This RFI is for planning purposes only and should not be construed as a solicitation for applications or proposals, or as an obligation in any way on the part of the United States federal government. The federal VerDate Sep<11>2014 18:57 Jan 12, 2024 Jkt 262001 government will not pay for the preparation of any information submitted or for the government’s use. Additionally, the government cannot guarantee the confidentiality of the information provided. Dated: January 6, 2024. Lawrence A. Tabak, Principal Deputy Director, National Institutes of Health. [FR Doc. 2024–00696 Filed 1–12–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting of the National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; Brain Initiative TMM RFA Review. Date: February 15, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Democracy II, Suite 920, 6707 Democracy Blvd., Bethesda, MD 20817 (Virtual Meeting). Contact Person: Alexander O. Komendantov, Ph.D., MS, Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 6707 Democracy Blvd., Bethesda, MD 20892, (301) 451–3397, alexander.komendantov@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health.) Dated: January 9, 2024. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–00627 Filed 1–12–24; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, March 06, 2024, 10:00 a.m. to March 06, 2024, 04:00 p.m., National Institutes of Health, NIDDK, Democracy II, Suite 7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 which was published in the Federal Register on November 07, 2023, 88 FR 77326. This meeting notice is amended to change the date from 3/06/2024 to 3/05/ 2024. The meeting is closed to the public. Dated: January 9, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–00626 Filed 1–12–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY U.S. Customs and Border Protection Test Concerning Entry of Section 321 Low-Value Shipments Through the Automated Commercial Environment (ACE) (Also Known as Entry Type 86); Republication With Modifications U.S. Customs and Border Protection, Department of Homeland Security. ACTION: General notice. AGENCY: This document republishes with modifications and supersedes a U.S. Customs and Border Protection (CBP) notice published in the Federal Register on August 13, 2019, announcing a test to allow certain lowvalue shipments, including those shipments subject to Partner Government Agency (PGA) data requirements, to be entered by filing a new type of informal entry electronically in the Automated Commercial Environment (ACE). The test is known as the ACE Entry Type 86 Test. This document modifies the ACE Entry Type 86 Test to clarify the waiver of certain regulations and consequences of misconduct by test participants. In addition, this document makes minor technical changes to the original notice. DATES: The ACE Entry Type 86 Test commenced September 28, 2019, and SUMMARY: E:\FR\FM\16JAN1.SGM 16JAN1

Agencies

[Federal Register Volume 89, Number 10 (Tuesday, January 16, 2024)]
[Notices]
[Pages 2629-2630]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-00696]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Information (RFI): Inviting Comments on the National 
Institutes of Health's (NIH) Strategic Plan for Data Science 2023-2028

AGENCY: National Institutes of Health, HHS.

ACTION: Request for information.

-----------------------------------------------------------------------

SUMMARY: The purpose of this Request for Information (RFI) is to 
solicit public comments on the updated NIH Strategic Plan for Data 
Science, 2023-2028, including members of the scientific community, 
academic institutions, the private sector, health professionals, 
professional societies, advocacy groups, and patient communities, as 
well as other interested members of the public.

DATES: The NIH Request for Information is open for public comment. To 
assure consideration, your response must be received by March 15, 2024, 
11:59 p.m. (ET).

ADDRESSES: All comments must be submitted electronically on the 
submission website at https://datascience.nih.gov/rfi-strategic-plan or 
to the mailbox at [email protected].
    Responses must be received by 11:59:59 p.m. (ET) on March 15, 2024.
    Responses to this RFI are voluntary and may be submitted 
anonymously. You may voluntarily include your name and contact 
information with your response. If you choose to provide NIH with this 
information, NIH will not share your name and contact information 
outside of NIH unless required by law.
    Other than your name and contact information, please do not include 
any personally identifiable information or any information that you do 
not wish to make public. Proprietary, classified, confidential, or 
sensitive information should not be included in your response. The 
government will use the information submitted in response to this RFI 
at its discretion. Other than your name and contact information, the 
government reserves the right to use any submitted information on 
public websites, in reports, in summaries of the state of the science, 
in any possible resultant solicitation(s), grant(s), or cooperative 
agreement(s), or in the development of future funding opportunity 
announcements. This RFI is for informational and planning purposes only 
and is not a solicitation for applications or an obligation on the part 
of the government to provide support for any ideas identified in 
response to it. Please note that the government will not pay for the 
preparation of any information submitted or for use of that 
information.
    We look forward to your input and hope that you will share this RFI 
opportunity with your colleagues.

FOR FURTHER INFORMATION CONTACT: Questions about this request for 
information should be directed to Dr. Susan Gregurick, 301-538-9781, 
[email protected], National Institutes of Health, Office of 
Data Science Strategy, 9000 Rockville Pike, Bethesda, Maryland 20892.

SUPPLEMENTARY INFORMATION: NIH is requesting public comment on topics 
under consideration for the updated NIH Strategic Plan for Data 
Science, 2023-2028 from its partners and collaborators, including 
members of the scientific community, academic institutions, the private 
sector, health professionals, professional societies, advocacy groups, 
and patient communities, as well as other interested members of the 
public. This RFI is in accordance with 42 U.S.C. 281 as amended.

Background

    The updated Strategic Plan for Data Science (https://datascience.nih.gov/sites/default/files/NIH-STRATEGIC-PLAN-FOR-DATA-SCIENCE-2023-2028-final-draft.pdf) sets a bold vision for the future, 
one in which data generated in the course of care of individuals and 
data generated from biomedical and basic research become powerful 
inputs that enhance our understanding of fundamental biology and 
enables the development of new clinical treatments and diagnostic 
technologies. This updated plan builds on accomplishments from the 
initial NIH Strategic Plan for Data Science (https://datascience.nih.gov/nih-strategic-plan-data-science) and will prepare 
NIH to face the acceleration of sophisticated new technologies and 
address the rapid rise in the quantity and diversity of data. The 
updated Strategic Plan supports the NIH Policy for Data Management and 
Sharing (https://sharing.nih.gov/data-management-and-sharing-policy) 
and embraces data-

[[Page 2630]]

driven discovery as a powerful tool to elucidate biological processes 
and better characterize the health and health consequences of all 
people. This plan also fosters ethical use of new methodologies arising 
from artificial intelligence and machine learning.
    The updated Strategic Plan will accomplish five overarching goals:

 Goal 1: Improve Capabilities to Sustain the NIH Policy for 
Data Management and Sharing
 Goal 2: Develop Programs to Enhance Human Derived Data for 
Research
 Goal 3: Provide New Opportunities in Software, Computational 
Methods, and Artificial Intelligence
 Goal 4: Support for a Federated Biomedical Research Data 
Infrastructure
 Goal 5: Strengthen a Broad Community in Data Science

    The complete draft plan is available at: https://datascience.nih.gov/sites/default/files/NIH-STRATEGIC-PLAN-FOR-DATA-SCIENCE-2023-2028-final-draft.pdf.

Information Requested

    NIH is requesting public comment throughout the scientific research 
community and members of the general public for the updated NIH 
Strategic Plan for Data Science. NIH encourages organizations (e.g., 
patient advocacy groups, professional organizations) to submit a single 
response reflective of the views of the organization or membership as a 
whole.
    Response to this RFI is voluntary. Respondents are free to address 
any or all topics listed below, as well as other relevant topics, for 
NIH's consideration. If you choose to provide NIH with this 
information, NIH will not share your name and contact information 
outside of NIH unless required by law.
    The NIH seeks comments on any of the following topics:
     The appropriateness of the goals of the plan, the 
strategies and implementation tactics proposed to achieve them; 
including potential benefits, drawbacks or challenges.
     Opportunities for NIH to partner to achieve these goals.
     Emerging research needs and opportunities that should be 
added to the plan.
     Any other topic the respondent feels is relevant for NIH 
to consider in developing this strategic plan.
    This RFI is for planning purposes only and should not be construed 
as a solicitation for applications or proposals, or as an obligation in 
any way on the part of the United States federal government. The 
federal government will not pay for the preparation of any information 
submitted or for the government's use. Additionally, the government 
cannot guarantee the confidentiality of the information provided.

    Dated: January 6, 2024.
Lawrence A. Tabak,
Principal Deputy Director, National Institutes of Health.
[FR Doc. 2024-00696 Filed 1-12-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.